LRMR Larimar Therapeutics, Inc.
Healthcare$3.45-3.36%ClosedMarket Cap: $295.2M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$12.00
Target (Median)
$12.00
Target Range
$12.00 - $12.00
Upside from current price: 247.8%
Rating Distribution
1 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-20 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-25 | Citigroup | maintain | Buy | Buy |
| 2025-10-02 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-09-30 | Wedbush | maintain | Outperform | Outperform |
| 2025-09-30 | Baird | maintain | Outperform | Outperform |
| 2025-08-19 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-06-25 | Guggenheim | maintain | Buy | Buy |
| 2025-06-24 | Wedbush | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.27 | $60.2M | 5 |
| Sun Dec 31 | $-0.60 | $151.2M | 4 |
| Mon Dec 31 | $-0.11 | $267.9M | 2 |
| Tue Dec 31 | $0.68 | $383.4M | 2 |